Cargando…

Graves’ disease overlapping with chronic hepatitis B and methimazole-induced liver injury and autoimmune hepatitis: a case report

BACKGROUND: Liver injury related to Graves’ Disease (GD) includes hepatotoxicity of thyroid hormone excess, drug-induced liver injury, and changes resulting from concomitant liver disease. Methimazole (MMI) has been shown to induce several patterns of liver injury. However, the diagnosis and treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Meifang, Cui, Shiyuan, Zhang, Wei, Brigstock, David R., Gao, Runping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832775/ https://www.ncbi.nlm.nih.gov/pubmed/35144533 http://dx.doi.org/10.1186/s12876-022-02133-z

Ejemplares similares

Activation of nuclear factor kappa B (NF-κB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cells
por: Gao, Runping, et al.
Publicado: (2005)

Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease
por: Roh, Eun, et al.
Publicado: (2013)

Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ Disease
por: Wijaya, Natalia, et al.
Publicado: (2019)

Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease
por: Lee, Sun Hee, et al.
Publicado: (2013)

Mitigation of Methimazole-Induced Hepatic Injury by Taurine in Mice
por: Heidari, Reza, et al.
Publicado: (2015)

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
por: Papamichalis, Panagiotis A, et al.
Publicado: (2007)

A Case of Methimazole-Induced Acute Hepatic Failure in A Patient With Chronic Hepatitis B Carrier
por: Kang, Hun, et al.
Publicado: (1990)

Methimazole-Induced Pleural Effusion in the Setting of Graves' Disease
por: Khine, Le Yu, et al.
Publicado: (2019)

Methimazole-induced insulin autoimmune syndrome in Graves' disease with hypokalemia: A case report and literature review
por: Han, Rongfeng, et al.
Publicado: (2020)

Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children
por: Rivkees, Scott A., et al.
Publicado: (2010)

Polyarthritis Caused by Methimazole in Two Japanese Patients with Graves’ Disease
por: Nihei, Hiroko, et al.
Publicado: (2013)

Case report: hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in young Taiwanese woman with Graves’ disease
por: Wu, Hsuan-Yu, et al.
Publicado: (2022)

Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
por: Sugiura, Ayumi, et al.
Publicado: (2017)

SAT-582 Autoimmune Hepatitis Presenting with Graves Disease
por: Coy, Andres, et al.
Publicado: (2019)

Challenges in Management of Autoimmune Hepatitis With Concurrent Graves Thyrotoxicosis
por: Nguyen, Ngan, et al.
Publicado: (2019)

Methimazole-induced cholestatic hepatitis: two cases report and literature review
por: Zou, Hai, et al.
Publicado: (2015)

SUN-517 Methimazole-Induced Neutropenia in Premature Twins with Graves’ Disease
por: Ballestas, Estefania Rodriguez, et al.
Publicado: (2020)

A Rare Case of Anaphylaxis to Methimazole in a Patient With Graves’ Disease
por: Garg, Dave, et al.
Publicado: (2021)

Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease
por: Schneider Aguirre, Rebecca, et al.
Publicado: (2021)

FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
por: Barua, Nabonita, et al.
Publicado: (2023)

Antithyroid arthritis syndrome caused by methimazole in a patient with Graves’ disease
por: Kawasumi, Muneo, et al.
Publicado: (2023)

Therapeutic Plasma Exchange as a Bridging Therapy for the Definitive Treatment of a Patient with Graves’ Disease and Methimazole-Induced Liver Injury
por: Purnamasari, Dyah, et al.
Publicado: (2023)

SUN-558 Methimazole Treatment of Thyrotoxicosis in the Setting of Ischemic Hepatitis
por: Chokshi, Sheel, et al.
Publicado: (2019)

Profound Hypothyroidism 21 Days After Methimazole Initiation in a Patient With Graves’s Disease and Liver Cirrhosis
por: Hammami, Safa, et al.
Publicado: (2021)

Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves’s disease: a case report and literature review
por: Zeng, Jinhui, et al.
Publicado: (2021)

Impact of Methimazole Treatment on Magnesium Concentration and Lymphocytes Activation in Adolescents with Graves’ Disease
por: Klatka, Maria, et al.
Publicado: (2013)

A CASE OF AUTOIMMUNE HEPATITIS WITH GRAVES’ DISEASE TREATED BY PROPYLTHIOURACIL
por: SATO, IKUKO, et al.
Publicado: (2011)

Autoimmune Hepatitis with Multiple Sclerosis and Graves Disease: Coincidence or Association?
por: Nadhem, Omar N., et al.
Publicado: (2014)

Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave’s Disease
por: Sawhney, Rahul, et al.
Publicado: (2019)

SUN-502 Graves’Disease and Autoimmune Hepatitis: Management Challenges
por: Soares, Maria Marta Sarquis, et al.
Publicado: (2020)

Acute Severe Seronegative Autoimmune Hepatitis With Undiagnosed Graves’ Disease
por: Memon, Mohammad B, et al.
Publicado: (2022)

SUN-495 Rapid Resolution of Hyperthyroidism Induced Hepatic Dysfunction with Methimazole
por: Amir, Maryam, et al.
Publicado: (2020)

Changes of IgG N-Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves’ Disease and the Association With the Severity of Inflammation in Hashimoto’s Thyroiditis
por: Trzos, Sara, et al.
Publicado: (2022)

Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves’ Disease Before and After Methimazole Treatment
por: Yang, Mengxue, et al.
Publicado: (2022)

Initial Treatment of Pediatric Graves’ Disease with Methimazole: A Retrospective Follow-up Study
por: Matsushita, Rie, et al.
Publicado: (2010)

Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves’ disease
por: Puthenpura, Vidya, et al.
Publicado: (2016)

Evaluating the Role of Circulating Dendritic Cells in Methimazole-Treated Pediatric Graves’ Disease Patients
por: Starosz, Aleksandra, et al.
Publicado: (2021)

Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
por: Lee, Hyun Gyung, et al.
Publicado: (2021)

THU669 Time To Achieve Euthyroidism In Graves Disease Using Methimazole In An Urban Population
por: Sultana Habbsa, Samima, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e9r3qkh63bm6c9855c9ftnnfhk